CTOs on the Move


 
NERI is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Watertown, MA. To find more information about NERI, please visit www.neriscience.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Stillwater Medical Center

Stillwater Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Stillwater, OK. To find more information about Stillwater Medical Center, please visit www.stillwater-medical.org

Binson's Home Health Care Centers

Binson's Home Health Care Centers is a Center Line, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Flagler Hospital

Rich history mixed with innovative technology is an integral part of Flagler Hospital in historic St. Augustine, Florida. Since its founding in 1889, our private, not-for-profit facility has grown into a 335 bed, acute care center that is consistently recognized nationally for overall clinical excellence. The hospital has consistently ranked among the top 5% in the nation for clinical excellence and patient safety for nearly a decade and was Northeast Florida`s first hospital to receive the ANCC Magnet hospital award. Most recently, the hospital earned five stars for heart attack treatment, the Gold Seal of Approvalâ„¢ from The Joint Commission for Primary Stroke Care Centers, Center of Excellence Designation for its Bariatric Surgery Center, and national accreditation for total knee and total hip replacement surgery.

Medical Practice Management Services

Medical Practice Management Services is a Coeur D Alene, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.